Find Macimorelin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

64 RELATED EXCIPIENT COMPANIES

106EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ard-07, Aezs-130, 381231-18-1, Ep-1572, Jmv-1843, Ard 07
Molecular Formula
C26H30N6O3
Molecular Weight
474.6  g/mol
InChI Key
UJVDJAPJQWZRFR-DHIUTWEWSA-N
FDA UNII
8680B21W73

Macimorelin
Macimorelin is an orally available synthetic mimetic of the growth hormone (GH) secretagogue ghrelin with potential anti-cachexia activity. Upon oral administration, macimorelin mimics endogenous ghrelin by stimulating appetite and binds to the growth hormone secretagogue receptor GHSR in the central nervous system, thereby mimicking the GH-releasing effects of ghrelin from the pituitary gland. Stimulation of GH secretion increases insulin-like growth factor-I (IGF-I) levels which may further stimulate protein synthesis. In addition, ghrelin reduces the production of pro-inflammatory cytokines, which may play a direct role in cancer-related loss of appetite.
Macimorelin is a Growth Hormone Secretagogue Receptor Agonist. The mechanism of action of macimorelin is as a Growth Hormone Secretagogue Receptor Agonist.
1 2D Structure

Macimorelin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide
2.1.2 InChI
InChI=1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/t22-,23-/m1/s1
2.1.3 InChI Key
UJVDJAPJQWZRFR-DHIUTWEWSA-N
2.1.4 Canonical SMILES
CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CNC4=CC=CC=C43)NC=O)N
2.1.5 Isomeric SMILES
CC(C)(C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC3=CNC4=CC=CC=C43)NC=O)N
2.2 Other Identifiers
2.2.1 UNII
8680B21W73
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Aezs-130

2. Aib-dtrp-dgtrp-cho

3. Aib-trp-gtrp-cho

4. Aminoisobutyryl-tryptophyl-tryptophanamine-formyl

5. Ard-07

6. Ep 1572

7. Ep-1572

8. Ep1572

9. Jmv 1843

10. Jmv-1843

11. Jmv1843

12. Macimorelin Acetate

13. Macrilen

2.3.2 Depositor-Supplied Synonyms

1. Ard-07

2. Aezs-130

3. 381231-18-1

4. Ep-1572

5. Jmv-1843

6. Ard 07

7. Jmv 1843

8. Ep 1572

9. Ep-01572

10. Chembl278623

11. 381231-18-1 (free Base)

12. Ep1572

13. Macimorelin (usan)

14. 8680b21w73

15. Macimorelin [usan]

16. D-87575

17. 2-amino-n-((r)-1-(((r)-1-formamido-2-(1h-indol-3-yl)ethyl)amino)-3-(1h-indol-3-yl)-1-oxopropan-2-yl)-2-methylpropanamide

18. 2-amino-n-[(2r)-1-[[(1r)-1-formamido-2-(1h-indol-3-yl)ethyl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide

19. Macimorelin [inn]

20. Macimorelin [usan:inn]

21. Unii-8680b21w73

22. Aib-dtrp-dgtrp-cho

23. Macimorelin [mi]

24. Aezs130

25. Macimorelin [who-dd]

26. Gtpl9745

27. Schembl1984708

28. Jmv1843

29. Umv1843

30. Dtxsid601045766

31. Glxc-25240

32. Bdbm50125886

33. Db13074

34. Ep01572

35. Hy-14820

36. Cs-0003577

37. D10563

38. Aminoisobutyryl-tryptophyl-tryptophanamine-formyl

39. Q15624037

40. 2-amino-n-{(r)-1-[(r)-1-formylamino-2-(1h-indol-3-yl)-ethylcarbamoyl]-2-1h-indol-3-yl-ethyl}-2-methyl-propionamide

41. N(sup 2)-(2-amino-2-methylpropanoyl-n1-((1r)-1-formamido-2-(1h-indol-3-yl)ethyl)-d-tryptophanamide

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 474.6 g/mol
Molecular Formula C26H30N6O3
XLogP31.8
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count4
Rotatable Bond Count9
Exact Mass474.23793884 g/mol
Monoisotopic Mass474.23793884 g/mol
Topological Polar Surface Area145 Ų
Heavy Atom Count35
Formal Charge0
Complexity761
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Indicated for the diagnosis of adult growth hormone deficiency (AGHD).


FDA Label


This medicinal product is for diagnostic use only. GHRYVELIN is indicated for the diagnosis of growth hormone deficiency (GHD) in adults.


Diagnosis of growth hormone deficiency


5 Pharmacology and Biochemistry
5.1 Pharmacology

Maximum GH levels from stimulation are observed between 30 to 90 minutes after administration of macimorelin. Increase in the QTcF interval may be observed from macimorelin administration.


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
MACIMORELIN
5.2.2 FDA UNII
8680B21W73
5.2.3 Pharmacological Classes
Mechanisms of Action [MoA] - Growth Hormone Secretagogue Receptor Agonists
5.3 ATC Code

V04CD06


V - Various

V04 - Diagnostic agents

V04C - Other diagnostic agents

V04CD - Tests for pituitary function

V04CD06 - Macimorelin


5.4 Absorption, Distribution and Excretion

Absorption

Macimorelin is a novel, synthetic ghrelin agonist, which is readily absorbed from the gastrointestinal tract. The maximum plasma concentration (Cmax) was observed between 0.5 and 1.5 hours following oral administration of 0.5mg/kg macimorelin to patients with AGHD under fasting for at least 8 hours. Higher doses of drug demonstrate a dose-proportional increase in plasma concentrations. A liquid meal decreased the macimorelin Cmax and AUC by 55% and 49%, respectively.


Volume of Distribution

Following a single oral dose of 0.5 mg/kg macimorelin, the mean volume of distribution of the central compartment is 5,733.4 565.7L.


Clearance

Following a single oral dose of 0.5 mg/kg macimorelin, the mean clearance over the fraction absorbed (Cl/F) was 37,411.0 4,554.6 mL/min.


5.5 Metabolism/Metabolites

Macimorelin predominantly undergoes CYP3A4-mediated metabolism according to an *in vitro* human liver microsomes study.


5.6 Biological Half-Life

The mean terminal half-life (T1/2) is 4.1 hours following administration of a single oral dose of 0.5 mg macimorelin/kg body weight in healthy subjects.


5.7 Mechanism of Action

Ghrelin is an endogenous ligand for the GH secretagogue receptor that is also called the ghrelin receptor (GHS-R1a). Upon activation of the receptor, ghrelin serves to increase growth hormone (GH) secretion. Macimorelin mimics the actions of ghrelin by stimulating GH release. As a synthetic agonist, it activates growth hormone secretagogue receptors present in the pituitary and hypothalamus.


Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Co-Processed Excipients

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Solubilizers

read-more
read-more

Coating Systems & Additives

read-more
read-more

Emulsifying Agents

read-more
read-more

Parenteral

read-more
read-more

API Stability Enhancers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

ABOUT THIS PAGE

Macimorelin Manufacturers

A Macimorelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Macimorelin, including repackagers and relabelers. The FDA regulates Macimorelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Macimorelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Macimorelin Suppliers

A Macimorelin supplier is an individual or a company that provides Macimorelin active pharmaceutical ingredient (API) or Macimorelin finished formulations upon request. The Macimorelin suppliers may include Macimorelin API manufacturers, exporters, distributors and traders.

Macimorelin NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Macimorelin as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Macimorelin API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Macimorelin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Macimorelin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Macimorelin NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Macimorelin suppliers with NDC on PharmaCompass.

Macimorelin GMP

Macimorelin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Macimorelin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Macimorelin GMP manufacturer or Macimorelin GMP API supplier for your needs.

Macimorelin CoA

A Macimorelin CoA (Certificate of Analysis) is a formal document that attests to Macimorelin's compliance with Macimorelin specifications and serves as a tool for batch-level quality control.

Macimorelin CoA mostly includes findings from lab analyses of a specific batch. For each Macimorelin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Macimorelin may be tested according to a variety of international standards, such as European Pharmacopoeia (Macimorelin EP), Macimorelin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Macimorelin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty